ARWR earnings: a negative outcome, -5.1%

On November 28, 2022, Arrowhead Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.1% in the window around the event. It had already run -17.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.